203 related articles for article (PubMed ID: 25655574)
1. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
[TBL] [Abstract][Full Text] [Related]
2. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.
Lee J; Mark RG; Celi LA; Danziger J
J Clin Pharmacol; 2016 Dec; 56(12):1500-1506. PubMed ID: 27492273
[TBL] [Abstract][Full Text] [Related]
6. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
[TBL] [Abstract][Full Text] [Related]
7. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.
Chrysant SG
Expert Rev Cardiovasc Ther; 2019 May; 17(5):345-351. PubMed ID: 31092056
[No Abstract] [Full Text] [Related]
10. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
[TBL] [Abstract][Full Text] [Related]
11. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.
Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients.
Shi L; Zhang D
J Clin Pharmacol; 2020 Jul; 60(7):860-866. PubMed ID: 32043627
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
Bai AD; Wilkinson A; Almufleh A; Rai M; Razak F; Verma AA; Srivastava S
JAMA Netw Open; 2023 Oct; 6(10):e2339893. PubMed ID: 37883084
[TBL] [Abstract][Full Text] [Related]
15. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
[TBL] [Abstract][Full Text] [Related]
17. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
[TBL] [Abstract][Full Text] [Related]
20. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]